David Scott Miller


AuthID: R-00K-250

Confirmed Publications: 319



21
TITLE: NCCN GUIDELINES® INSIGHTS CE Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024. Featured Updates to the NCCN Guidelines
AUTHORS: Joyce Liu; Andrew Berchuck; Floor J Backes; Joshua Cohen; Rachel Grisham; Charles A Leath; Lainie Martin; Daniela Matei; David Scott Miller ; Sharon Robertson; Lisa Barroilhet; Shitanshu Uppal; Andrea Wahner Hendrickson; David M Gershenson; Heidi J Gray; Ardeshir Hakam; Angela Jain; Gottfried E Konecny; John Moroney; Elena Ratner; John Schorge; Premal H Thaker; Theresa L Werner; Emese Zsiros; Kian Behbakht; Lee May Chen; Marie DeRosa; Eric L Eisenhauer; Gary Leiserowitz; Babak Litkouhi; Michael McHale; Sanja Percac Lima; Kerry Rodabaugh; Roberto Vargas; Frankie Jones; Emily Kovach; Lisa Hang; Swathi Ramakrishnan; Ronald D Alvarez; Deborah K Armstrong; ...More
PUBLISHED: 2024, SOURCE: Jnccn Journal of the National Comprehensive Cancer Network, VOLUME: 22, ISSUE: 8
INDEXED IN: Scopus CrossRef
IN MY: ORCID
22
TITLE: Phase 3 dose selection for selinexor in TP53wt endometrial cancer based on exposure-response analysis.
AUTHORS: Vicky Makker; Debra L Richardson; Hye Sook Chon; David Scott Miller ; Morten Mau-Sørensen; David Cibula; Flora Zagouri; Alejandro Pérez Fidalgo; Brian M Slomovitz; Robert L Coleman; Pratheek Kalyanapu; Rong Fan; Girish Gudi; Ignace Vergote;
PUBLISHED: 2024, SOURCE: Journal of Clinical Oncology, VOLUME: 42, ISSUE: 16_suppl
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
23
TITLE: Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279
AUTHORS: Neil S Horowitz; Wei Deng; Ivy Peterson; Robert S Mannel; Spencer Thompson; Elizabeth Lokich; Tashanna Myers; Parvis Hanjani; David M O'Malley; Ki Young Chung; David Scott Miller ; Frederick R Ueland; Don S Dizon; Austin Miller; Jyoti S Mayadev; Charles A Leath; Bradley J Monk;
PUBLISHED: 2024, SOURCE: Journal of Clinical Oncology, VOLUME: 42, ISSUE: 16
INDEXED IN: Scopus CrossRef Unpaywall
IN MY: ORCID
24
TITLE: Predicting Vte and Utility of Thromboprophylaxis in Metastatic and Recurrent Cervical Cancer
AUTHORS: Christopher A Walker; Carson Edwards; Don McIntire; Lydia Makepeace; Steven B Holloway; Ev Kakadiaris; Alexandra Spirtos; David Scott Miller ; Jayanthi Lea;
PUBLISHED: 2024
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
25
TITLE: Predicting VTE and utility of thromboprophylaxis in metastatic and recurrent cervical cancer  Full Text
AUTHORS: Christopher A Walker; Carson Edwards; Don McIntire; Lydia Makepeace; Steven Blaine Holloway; Ev Kakadiaris; Alexandra N Spirtos; David Scott Miller ; Jayanthi S Lea;
PUBLISHED: 2024, SOURCE: Gynecologic Oncology, VOLUME: 188
INDEXED IN: Scopus CrossRef
IN MY: ORCID | CIÊNCIAVITAE
26
TITLE: Radiation Therapy with or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results from an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial
AUTHORS: Ann H Klopp; Danielle Enserro; Matthew Powell; Marcus Randall; Julian C Schink; Robert S Mannel; Laura Holman; David Bender; Christina L Kushnir; Floor Backes; Susan L Zweizig; Steven Waggoner; Kristin A Bradley; Lana Desouza Lawrence; Parviz Hanjani; Christopher J Darus; William Small; Higinia R Cardenes; Jonathan M Feddock; David Scott Miller ;
PUBLISHED: 2024, SOURCE: Journal of Clinical Oncology, VOLUME: 42, ISSUE: 20
INDEXED IN: Scopus CrossRef: 3
IN MY: ORCID | CIÊNCIAVITAE
27
TITLE: Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14  Full Text
AUTHORS: Jubilee Brown; Austin Miller; Laura L Holman; Floor Backes; Christa Nagel; David Bender; David Scott Miller ; Matthew A Powell; Shannon N Westin; Albert Bonebrake; Carolyn Y Muller; Angeles Alvarez Secord; Erin Crane; John Schorge; William P Tew; Anil K Sood; Michael A Bookman; Carol Aghajanian; David M Gershenson;
PUBLISHED: 2024, SOURCE: Gynecologic Oncology, VOLUME: 190
INDEXED IN: Scopus CrossRef
IN MY: ORCID | CIÊNCIAVITAE
28
TITLE: Social determinants of health in uterine carcinosarcoma
AUTHORS: Larissa L Aroche Gutierrez; Donald D McIntire; Jayanthi Lea; Salvatore LoCoco; David Scott Miller ;
PUBLISHED: 2024, SOURCE: Gynecologic Oncology, VOLUME: 184
INDEXED IN: Scopus CrossRef Unpaywall
IN MY: ORCID | CIÊNCIAVITAE
29
TITLE: A phase II trial evaluating cisplatin and gemcitabine concurrent with intensity-modulated radiation therapy (IMRT) for the treatment of locally advanced squamous cell carcinoma of the vulva: NRG oncology trial #279 (004)  Full Text
AUTHORS: Neil Horowitz; Wei Deng; Ivy Petersen; Spencer S Thompson; Robert Mannel; Elizabeth Lokich; Sharon Robertson; Tashanna Myers; Parviz Hanjani; David O'Malley; Ki Young Chung; David Scott Miller ; Frederick Ueland; Don Dizon; Austin Miller; Bradley Monk;
PUBLISHED: 2023, SOURCE: Gynecologic Oncology, VOLUME: 176
INDEXED IN: CrossRef: 4
IN MY: ORCID | CIÊNCIAVITAE
30
TITLE: Adenocarcinoma of the uterine corpus and sarcomas of the uterus
AUTHORS: William T Creasman; David Scott Miller ; Ramez N Eskander; Matthew Powell;
PUBLISHED: 2023, SOURCE: DiSaia and Creasman Clinical Gynecologic Oncology
INDEXED IN: Scopus CrossRef
IN MY: ORCID | CIÊNCIAVITAE
Page 3 of 32. Total results: 319.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service